Gyrus Capital completed a $68m investment in Neo Medical.

Gyrus Capital, a private equity firm, completed a $68m investment in Neo Medical, a Swiss technology company specializing in spine surgery. "Neo Medical’s vision and product platform has already proven itself in Europe and is poised to expand rapidly in the US. The sustainable commercialization of Neo’s integrated portfolio of technologies and innovative service model strategically positions the company to scale and capitalize on evolving market trends, including within outpatient centers. We are excited to partner with the management team and support Neo’s vision in redefining patient care," Robert Watson, Gyrus Partner and Co-Founder.